Clinical Trials in Illinois

Showing 1201-1220 of 19,692 trials

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

NCT05992935

The purpose of the Part A Phase 1 of this study is to evaluate the safety, reactogenicity, and immunogenicity of mRNA-1403 and mRNA-1405 in healthy adult participants 18 to 49 years of age and 60 to 80 years of age. The purpose of Part B Phase 2 and Part C Phase 2 is to evaluate the safety, reactogenicity, and immunogenicity of mRNA-1403 in healthy adult participants (18 to 80 years of age).

Norovirus Acute Gastroenteritis

ModernaTX, Inc.1,407 participantsStarted Aug 2023

Long Beach, California, United States • Longmont, Colorado, United States • Hollywood, Florida, United States +13 more locations

Active Not RecruitingPhase 3105 miles

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

NCT06668064

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

EyePoint Pharmaceuticals, Inc.400 participantsStarted Oct 2024

Phoenix, Arizona, United States • Springdale, Arkansas, United States • Bakersfield, California, United States +76 more locations

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56

Find Trials by Condition in Illinois

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

Cryoprobe Versus Forceps for Transbronchial Biopsy

A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection

A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

A Study of LY3200882 in Participants With Solid Tumors

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors